Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001683168-20-003145
Filing Date
2020-09-16
Accepted
2020-09-16 09:25:18
Documents
25
Period of Report
2020-09-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO CURRENT REPORT cns_8ka.htm 8-K/A 20945
2 PRESENTATION cns_ex9901.htm EX-99.1 40945
3 GRAPHIC image_001.jpg GRAPHIC 174200
4 GRAPHIC image_002.jpg GRAPHIC 134591
5 GRAPHIC image_003.jpg GRAPHIC 164948
6 GRAPHIC image_004.jpg GRAPHIC 251211
7 GRAPHIC image_005.jpg GRAPHIC 132416
8 GRAPHIC image_006.jpg GRAPHIC 239331
9 GRAPHIC image_007.jpg GRAPHIC 232352
10 GRAPHIC image_008.jpg GRAPHIC 181430
11 GRAPHIC image_009.jpg GRAPHIC 246672
12 GRAPHIC image_010.jpg GRAPHIC 188206
13 GRAPHIC image_011.jpg GRAPHIC 179324
14 GRAPHIC image_012.jpg GRAPHIC 203638
15 GRAPHIC image_013.jpg GRAPHIC 266357
16 GRAPHIC image_014.jpg GRAPHIC 199058
17 GRAPHIC image_015.jpg GRAPHIC 265270
18 GRAPHIC image_016.jpg GRAPHIC 174039
19 GRAPHIC image_017.jpg GRAPHIC 269218
20 GRAPHIC image_018.jpg GRAPHIC 143999
21 GRAPHIC image_019.jpg GRAPHIC 156601
22 GRAPHIC image_020.jpg GRAPHIC 235223
23 GRAPHIC image_021.jpg GRAPHIC 179704
24 GRAPHIC image_022.jpg GRAPHIC 177452
25 GRAPHIC image_023.jpg GRAPHIC 174200
  Complete submission text file 0001683168-20-003145.txt   6359599
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39126 | Film No.: 201177545
SIC: 2834 Pharmaceutical Preparations